1. HBW Insight
  2. >>Health
  3. >>Business

Dialing Up Toothbrush Smartphone Apps: P&G's 3D Imaging, Colgate's Personalized ‘Sensors’

 
• By Eileen Francis

P&G launches Oral-B iO rechargeable toothbrush priced at between $199-$299 and promoted with a 15-second TV spot. In September, Colgate will introduce Hum by Colgate toothbrush using sensors that can gauge personalized brushing style for more accurate cleaning.

PG IO toothbrush
P&G's latest Oral-B rechargeable toothbrush is its highest-priced and uses three-dimensional tooth imaging to guide professional-grade cleaning.

Technology is increasing along with competition in the US oral care market as two of the largest firms in the sector launch power toothbrushes linked to smartphone apps to help guide users to improve their brushing.

Procter & Gamble’s latest Oral-B rechargeable toothbrush is its highest-priced and uses three-dimensional tooth imaging to guide professional-grade cleaning. Colgate-Palmolive Co., meanwhile, is offering a brush with sensors...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

Galenica’s Verfora Gets Off To Flying Start In Swiss CHC Market

 
• By Tom Gallen

Verfora grows almost 10-times faster than the Swiss consumer health market in the opening months of 2025.

People On The Move: Appointments at Hermes, Assosalute, Moberg

 
• By Tom Gallen

A round up of the latest European consumer health exec moves: Hermes hires management board chair; Assosalute elects directors; Moberg appoints ex-Orkla Health CEO.

IQVIA Consumer Health: Digestive Category Driving Global OTC Market Growth

 
• By David Ridley

An increasing awareness of and interest in gut health helped the global OTC market grow by 4.6% in value terms in 2024, according to IQVIA Consumer Health.

Alliance Pharma’s New Owners Will Instill ‘More Consumer-Oriented Mindset’

 
• By Tom Gallen

Private equity firms now in control of Alliance Pharma weighing úp plan to offload Rx business to help finance strategy to drive up sales and growth.

More from Health

‘We Must Have The Truth’ – Calls For UWWTD Review Intensify As Evidence Looks ‘Shaky’

 
• By David Ridley

The evidence underpinning the “polluter pays” principle of the revised Urban Wastewater Treatment Directive - which calls on Europe's pharmaceutical industry to cough up at least 80% of the cost of updating wastewater treatment facilities - is looking increasingly shaky, according to a new report.

People On The Move: Appointments at Hermes, Assosalute, Moberg

 
• By Tom Gallen

A round up of the latest European consumer health exec moves: Hermes hires management board chair; Assosalute elects directors; Moberg appoints ex-Orkla Health CEO.

Loper Bright ‘Might Not Be Cataclysmic’ With FDA’s ‘Good Reputation’ For Science – Attorney

 
• By Malcolm Spicer

Bridget Dooling, law school professor who reviewed draft regulations from FDA and other agencies as OMB attorney, says history of federal court decisions in litigation challenging FDA’s interpretation of statutes points to judges typically defer to agency decisions based in science.